Federal Register / Vol. 87, No. 109 / Tuesday, June 7, 2022 / Notices 34751 

1These criteria may be found in APPENDIX A TO 

PART 391—MEDICAL ADVISORY CRITERIA, 

section H. Epilepsy: § 391.41(b)(8), paragraphs 3, 4, 

and 5, which is available on the internet at https:// 

www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/ 

CFR-2015-title49-vol5-part391-appA.pdf. 

1200 New Jersey Avenue SE, 

Washington, DC 20590–0001, between 9 

a.m. and 5 p.m., ET, Monday through 

Friday, except Federal holidays. To be 

sure someone is there to help you, 

please call (202) 366–9317 or (202) 366– 

9826 before visiting Dockets Operations. 

B. Privacy Act 

In accordance with 49 U.S.C. 

31315(b)(6), DOT solicits comments 

from the public on the exemption 

request. DOT posts these comments, 

without edit, including any personal 

information the commenter provides, to 

www.regulations.gov, as described in 

the system of records notice (DOT/ALL– 

14 FDMS), which can be reviewed at 

www.dot.gov/privacy. 

II. Background 

On October 1, 2021, FMCSA 

published a notice announcing its 

decision to renew exemptions for five 

individuals from the epilepsy and 

seizure disorders prohibition in 49 CFR 

391.41(b)(8) to operate a CMV in 

interstate commerce and requested 

comments from the public (86 FR 

54505). The public comment period 

ended on November 1, 2021, and no 

comments were received. 

FMCSA has evaluated the eligibility 

of these applicants and determined that 

renewing these exemptions would 

achieve a level of safety equivalent to, 

or greater than, the level that would be 

achieved by complying with 

§ 391.41(b)(8). 

The physical qualification standard 

for drivers regarding epilepsy found in 

§ 391.41(b)(8) states that a person is 

physically qualified to drive a CMV if 

that person has no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause the loss of consciousness or any 

loss of ability to control a CMV. 

In addition to the regulations, FMCSA 

has published advisory criteria 1 to 

assist medical examiners in determining 

whether drivers with certain medical 

conditions are qualified to operate a 

CMV in interstate commerce. 

III. Discussion of Comments 

FMCSA received no comments in this 

proceeding. 

IV. Conclusion 

Based on its evaluation of the five 

renewal exemption applications, 

FMCSA announces its decision to 

exempt the following drivers from the 

epilepsy and seizure disorders 

prohibition in § 391.41(b)(8). 

In accordance with 49 U.S.C. 31136(e) 

and 31315(b), the following groups of 

drivers received renewed exemptions in 

the month of October and are discussed 

below. As of October 4, 2021, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following four individuals 

have satisfied the renewal conditions for 

obtaining an exemption from the 

epilepsy and seizure disorders 

prohibition in the FMCSRs for interstate 

CMV drivers (86 FR 54505): 

Daniel Maben (MI) 

Michael Miller (TX) 

William Swann (MD) 

Tyler Tilseth (NM) 

The drivers were included in docket 

number FMCSA–2014–0214, FMCSA– 

2017–0180, or FMCSA–2019–0033. 

Their exemptions were applicable as of 

October 4, 2021 and will expire on 

October 4, 2023. 

As of October 15, 2021, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), Adam Wilson (MN) has 

satisfied the renewal conditions for 

obtaining an exemption from the 

epilepsy and seizure disorders 

prohibition in the FMCSRs for interstate 

CMV drivers. This driver was included 

in docket number FMCSA–2019–0034. 

The exemption was applicable as of 

October 15, 2021 and will expire on 

October 15, 2023. 

In accordance with 49 U.S.C. 

31315(b), each exemption will be valid 

for 2 years from the effective date unless 

revoked earlier by FMCSA. The 

exemption will be revoked if the 

following occurs: (1) the person fails to 

comply with the terms and conditions 

of the exemption; (2) the exemption has 

resulted in a lower level of safety than 

was maintained prior to being granted; 

or (3) continuation of the exemption 

would not be consistent with the goals 

and objectives of 49 U.S.C. 31136(e) and 

31315(b). 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2022–12160 Filed 6–6–22; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2013–0106; 

FMCSA–2015–0017; FMCSA–2015–0320; 

FMCSA–2018–0058; FMCSA–2019–0036; 

FMCSA–2019–0206; FMCSA–2019–0210] 

Qualification of Drivers; Exemption 

Applications; Epilepsy and Seizure 

Disorders 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 

ACTION: Notice of final disposition. 

SUMMARY: FMCSA announces its 

decision to renew exemptions for eight 

individuals from the requirement in the 

Federal Motor Carrier Safety 

Regulations (FMCSRs) that interstate 

commercial motor vehicle (CMV) 

drivers have ‘‘no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause loss of consciousness or any 

loss of ability to control a CMV.’’ The 

exemptions enable these individuals 

who have had one or more seizures and 

are taking anti-seizure medication to 

continue to operate CMVs in interstate 

commerce. 

DATES: The exemptions were applicable 

on February 19, 2022. The exemptions 

expire on February 19, 2024. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, DOT, 

1200 New Jersey Avenue SE, Room 

W64–224, Washington, DC 20590–0001. 

Office hours are from 8:30 a.m. to 5 

p.m., ET, Monday through Friday, 

except Federal holidays. If you have 

questions regarding viewing or 

submitting material to the docket, 

contact Dockets Operations, (202) 366– 

9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Viewing Comments 

To view comments go to 

www.regulations.gov. Insert the docket 

number, FMCSA–2013–0106, FMCSA– 

2015–0017, FMCSA–2015–0320, 

FMCSA–2018–0058, FMCSA–2019– 

0036, FMCSA–2019–0206, or FMCSA– 

2019–0210 in the keyword box, and 

click ‘‘Search.’’ Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, and click ‘‘Browse 

Comments.’’ If you do not have access 

to the internet, you may view the docket 

online by visiting Dockets Operations in 

Room W12–140 on the ground floor of 


jspears on DSK121TN23PROD with NOTICES1
34752 Federal Register / Vol. 87, No. 109 / Tuesday, June 7, 2022 / Notices 

1These criteria may be found in APPENDIX A TO 

PART 391—MEDICAL ADVISORY CRITERIA, 

section H. Epilepsy: § 391.41(b)(8), paragraphs 3, 4, 

and 5, which is available on the internet at https:// 

www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/ 

CFR-2015-title49-vol5-part391-appA.pdf. 

the DOT West Building, 1200 New 

Jersey Avenue SE, Washington, DC 

20590–0001, between 9 a.m. and 5 p.m., 

ET, Monday through Friday, except 

Federal holidays. To be sure someone is 

there to help you, please call (202) 366– 

9317 or (202) 366–9826 before visiting 

Dockets Operations. 

B. Privacy Act 

In accordance with 49 U.S.C. 

31315(b)(6), DOT solicits comments 

from the public on the exemption 

request. DOT posts these comments, 

without edit, including any personal 

information the commenter provides, to 

www.regulations.gov, as described in 

the system of records notice (DOT/ALL– 

14 FDMS), which can be reviewed at 

www.dot.gov/privacy. 

II. Background 

On February 16, 2022, FMCSA 

published a notice announcing its 

decision to renew exemptions for eight 

individuals from the epilepsy and 

seizure disorders prohibition in 49 CFR 

391.41(b)(8) to operate a CMV in 

interstate commerce and requested 

comments from the public (87 FR 8919). 

The public comment period ended on 

March 18, 2022, and no comments were 

received. 

FMCSA has evaluated the eligibility 

of these applicants and determined that 

renewing these exemptions would 

achieve a level of safety equivalent to, 

or greater than, the level that would be 

achieved by complying with 

§ 391.41(b)(8). 

The physical qualification standard 

for drivers regarding epilepsy found in 

§ 391.41(b)(8) states that a person is 

physically qualified to drive a CMV if 

that person has no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause the loss of consciousness or any 

loss of ability to control a CMV. 

In addition to the regulations, FMCSA 

has published advisory criteria 1 to 

assist medical examiners in determining 

whether drivers with certain medical 

conditions are qualified to operate a 

CMV in interstate commerce. 

III. Discussion of Comments 

FMCSA received no comments in this 

proceeding. 

IV. Conclusion 

Based on its evaluation of the eight 

renewal exemption applications, 

FMCSA announces its decision to 

exempt the following drivers from the 

epilepsy and seizure disorders 

prohibition in § 391.41(b)(8). 

As of February 19, 2022, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following eight 

individuals have satisfied the renewal 

conditions for obtaining an exemption 

from the epilepsy and seizure disorders 

prohibition in the FMCSRs for interstate 

CMV drivers (87 FR 8919): 

Daniel Bretz Jr. (PA) 

Thomas DeAngelo (IL) 

Robert Drake (AZ) 

Pagagrong Newsome (CA) 

Tyler Schaefer (ME) 

Douglas Slagel (OH) 

Cory Wagner (IL) 

Randy Wentz (PA) 

The drivers were included in docket 

number FMCSA–2013–0106, FMCSA– 

2015–0017, FMCSA–2015–0320, 

FMCSA–2018–0058, FMCSA–2019– 

0036, FMCSA–2019–0206, or FMCSA– 

2019–0210. Their exemptions were 

applicable as of February 19, 2022 and 

will expire on February 19, 2024. 

In accordance with 49 U.S.C. 

31315(b), each exemption will be valid 

for 2 years from the effective date unless 

revoked earlier by FMCSA. The 

exemption will be revoked if the 

following occurs: (1) the person fails to 

comply with the terms and conditions 

of the exemption; (2) the exemption has 

resulted in a lower level of safety than 

was maintained prior to being granted; 

or (3) continuation of the exemption 

would not be consistent with the goals 

and objectives of 49 U.S.C. 31136(e) and 

31315(b). 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2022–12163 Filed 6–6–22; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

National Highway Traffic Safety 

Administration 

[Docket No. NHTSA–XXXX–XXXX] 

Public Workshop on Corporate 

Average Fuel Economy Reporting 

Templates 

AGENCY: National Highway Traffic 

Safety Administration (NHTSA), 

Department of Transportation (DOT). 

ACTION: Notification of rescheduled 

public workshop. 

SUMMARY: This notice announces that 

NHTSA will hold a workshop to present 

and demonstrate three compliance 

reporting templates for the Corporate 

Average Fuel Economy (CAFE) Program. 

Two of the templates will be required 

for reporting; the third template will be 

optional but is recommended for ease of 

reporting. The workshop will provide a 

demonstration of the use of the 

templates, which automobile 

manufacturers will use to provide 

NHTSA required compliance data. 

DATES: NHTSA will hold the public 

workshop on July 12, 2022 from 9 a.m. 

to 4:30 p.m., Eastern Standard Time. 

The workshop will be held virtually. 

Log-in on the day of the workshop will 

begin at 9 a.m. Attendance requires 

electronic registration and confirmation 

in advance and is free. 

ADDRESSES: Vehicle manufacturers and 

other interested parties who wish to 

attend the workshops are asked to preregister by June 30, 2022. Attendees 

should register online at https://

www.nhtsa.gov/events/workshop-cafereporting-template, by June 30, 2022. 

Registration is necessary for all 

attendees; please register even if you 

were previously registered for the 

workshop that was scheduled in January 

2022. Please provide your name, email 

address, and affiliation. Registrations 

may be accepted after that date, space 

permitting. Attendees are encouraged to 

submit questions related to reporting 

and credit related technical issues to be 

considered for discussion during the 

workshop. These questions should be 

submitted via email to cafe@dot.gov. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions about registering or 

connecting to the public workshop, 

please contact NHTSA staff at 

NHTSA.Communication@dot.gov or 

Chris LaMance at frederick.lamance@

dot.gov or (202) 366–7568. For questions 

concerning the workshop discussions 

contact Maurice Hicks at 

Maurice.Hicks@dot.gov or (202) 366– 

5289. 

We are committed to providing equal 

access to this event for all participants. 

Persons with disabilities in need of an 

accommodation should contact Maurice 

Hicks at (202) 366–5289 or, 

NHTSA.Communication@dot.gov to 

request an accommodation no later than 

July 5, 2022. 

SUPPLEMENTARY INFORMATION: 49 CFR 

part 537, ‘‘Automotive Fuel Economy 

Reports,’’ requires manufacturers to 

provide early model year projections on 

automobiles demonstrating how they 

intend to comply with CAFE standards. 

The regulation requires manufacturers 

to submit a pre-model year (PMY) report 

by December 31 before the model year 

and a mid-model year (MMY) report by 

July 31 of the model year. When NHTSA 

received and reviewed manufacturers’ 


jspears on DSK121TN23PROD with NOTICES1